On Wednesday, the FDA approved two rapid antigen home tests for use in the U.S. Americans will soon be able to purchase Abbott's BinaxNOW and Quidel Quickvue tests at drug stores. The two options join a test made by Ellume, which received FDA approval in December, in the market. The two, newly-approved swab tests will be sold at a lower price point. The BinaxNOW and Quickvue tests are expected to be sold in two-packs for around $15-20; Ellume costs $30.